Search Login Register
Language Development Disorders
(Semantic-Pragmatic Disorder)
Summary
113
relevant articles (3 outcomes,
16 trials/studies)
found for this Disease
Description:
Conditions characterized by language abilities (comprehension and expression of speech and writing) that are below the expected level for a given age, generally in the absence of an intellectual impairment. These conditions may be associated with DEAFNESS; BRAIN DISEASES; MENTAL DISORDERS; or environmental factors.
Also Known As:
Semantic-Pragmatic Disorder; Language Delay; Language Delays; Speech Delay; Auditory Processing Disorder, Central Show All >>
Key Drugs and Agents for Language Development Disorders
Efficacy Chart >>
Drugs and Important Biological Agents (IBA) related to treatments:
-
amsonic acid (DAS)
:
3 studies in 5 results
: IBA
-
Temazepam (Nocturne)
:
2 studies in 3 results
:
FDA 25
Generic
-
Methylphenidate (Ritalin)
:
1 study in 1 result
:
FDA 21
Generic
-
Glucose (Dextrose)
:
1 study in 1 result
:
FDA 183
Generic
-
mofezolac (N 22)
:
1 study in 1 result
: IBA
-
Aligeron (AS 2)
:
1 study in 1 result
: IBA
-
dicarboxydine (DCD)
:
1 study in 1 result
: IBA
-
Carbon Monoxide
:
9 results
: IBA
-
Creatine
:
7 results
: IBA
-
Cocaine (Cocaine HCl)
:
6 results
: IBA
Show All >>
Diseases Related to Language Development Disorders
-
Cleft Palate (Palate, Cleft)
-
Seizures (Seizure)
-
Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder)
-
Dyslexia (Alexia)
-
Apraxias (Dyspraxia)
Show All >>
Key Therapies for Language Development Disorders
Efficacy Chart >>
-
Speech Therapy (Therapy, Speech)
:
1 outcome 1 study in 4 results
-
Middle Ear Ventilation (Tympanostomy)
:
1 outcome in 4 results
-
Hemispherectomy
:
1 outcome in 1 result
-
Language Therapy (Language Training)
:
4 studies in 6 results
-
Continuous Ambulatory Peritoneal Dialysis (CAPD)
:
2 studies in 23 results
Show All >>
CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2008 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.